Q3 2020 13F Holders as of 30 Sep 2020
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
8,626,106
-
Share change
-
-81,619
-
Total reported value
-
$22,684,084
-
Price per share
-
$2.63
-
Number of holders
-
38
-
Value change
-
-$240,155
-
Number of buys
-
8
-
Number of sells
-
20
Institutional Holders of ELOXX PHARMACEUTICALS INC - COM (ELOX) as of Q3 2020
As of 30 Sep 2020,
ELOXX PHARMACEUTICALS INC - COM (ELOX) was held by
38 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
8,626,106 shares.
The largest 10 holders included
MENORA MIVTACHIM HOLDINGS LTD., BlackRock Inc., VANGUARD GROUP INC, Altshuler Shaham Ltd, Clal Insurance Enterprises Holdings Ltd, STATE STREET CORP, GEODE CAPITAL MANAGEMENT, LLC, NORTHERN TRUST CORP, BRIDGEWAY CAPITAL MANAGEMENT INC, and CHARLES SCHWAB INVESTMENT MANAGEMENT INC.
This page lists
38
institutional shareholders reporting positions in this security
for the Q3 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.